➤ Patients experience increased fatigue and decreased physical activity following the preparatory regimen and hematopoietic stem cell transplantation (HSCT).
I
ntensive cancer therapy, such as high-dose chemotherapy followed by hematopoietic stem cell transplantation (HSCT), has the potential to affect all aspects of patients' lives, particularly during the immediate post-transplant period. Very little is known about the patterns of fatigue, physical activity, health status, and quality of life (QOL) during this period. Problems such as fatigue and decreased physical activity may result in long-term functional consequences, eventually affecting patients' ability to maintain or return to productive roles in society. Obtaining subjective data during the acute post-transplant period is diffi cult because patients frequently are too ill to complete long questionnaires or participate in lengthy interviews. Likewise, obtaining objective Purpose/Objectives: To examine the patterns of fatigue, physical activity, health status, and quality of life before and after high-dose chemotherapy and hematopoietic stem cell transplantation (HSCT) and to examine the feasibility of obtaining real-time fatigue and physical activity data.
Design: Prospective, repeated measures. Setting: Two midwestern academic medical centers. Sample: Convenience sample of autologous or allogeneic patients undergoing HSCT (N = 20 baseline, N = 17 post-transplant).
Methods: Subjects were assessed over a fi ve-day period before and after HSCT for a total of 10 days. Subjects rated fatigue intensity three times daily and wore a wrist actigraph to measure physical activity. At the end of both fi ve-day periods, subjects completed measures of perceived health status (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30) and life satisfaction (Quality of Life Index).
Main Research Variables: Fatigue, physical activity, perceived health status, and quality of life.
Findings: Study results indicate that fatigue signifi cantly increased and physical activity decreased following high-dose chemotherapy and HSCT. The decline coincided with diminished physical, emotional, role, and cognitive functioning. The symptoms that patients experienced (i.e., fatigue, pain, nausea and vomiting, sleep disturbances, appetite loss, and diarrhea) increased during the acute post-transplant period. No signifi cant changes in life satisfaction were found.
Conclusions: The study findings suggest that patients receiving high-dose chemotherapy followed by HSCT experience increased fatigue, reduced physical activity, diminished functioning, and poorer quality of life immediately after transplant. Findings demonstrate that real-time fatigue and physical activity data can feasibly be collected in acutely ill patients.
Implications for Nursing: Patients undergoing HSCT require considerable supportive nursing care immediately following transplant. Clinicians and researchers need to strive for effective symptom management to improve the likelihood of successful outcomes. This material is protected by U.S. copyright law. Unauthorized reproduction is prohibited. To purchase quantity reprints, please e-mail reprints@ons.org or to request permission to reproduce multiple copies, please e-mail pubpermissions@ons.org.
